UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Volltextzugriff (PDF)

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Cancer, 2001-11, Vol.92 (9), p.2247-2258

2001

Volltextzugriff (PDF)

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1980-1986

2008

Volltextzugriff (PDF)

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2003-03, Vol.21 (6), p.968-975

2003

Volltextzugriff (PDF)

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Cancer, 2002-11, Vol.95 (9), p.2006-2016

2002

Volltextzugriff (PDF)

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3893-3901

2004

Volltextzugriff (PDF)

Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Oncotarget, 2018-04, Vol.9 (28), p.19463-19468

2018

Volltextzugriff (PDF)

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

JCO global oncology, 2021-12, Vol.7 (7), p.811-819

2021

Volltextzugriff (PDF)

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Critical reviews in oncology/hematology, 2015-07, Vol.95 (1), p.88-104

2015

Volltextzugriff (PDF)

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

The oncologist (Dayton, Ohio), 2001-01, Vol.6 (S3), p.5-12

2001

Volltextzugriff (PDF)

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Cancer, 2006-08, Vol.107 (3), p.472-480

2006

Volltextzugriff (PDF)

The emerging role of aromatase inhibitors in the adjuvant management of breast cancer

Reviews on recent clinical trials, 2006-09, Vol.1 (3), p.237-249

2006

Volltextzugriff (PDF)

Monotherapy of Metastatic Breast Cancer: A Review of Newer Agents

The oncologist (Dayton, Ohio), 1999-02, Vol.4 (1), p.17-33

1999

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Docetaxel in the treatment of breast cancer: An update on recent studies

Seminars in oncology, 2002-06, Vol.29 (3), p.28-34

2002

Volltextzugriff (PDF)

Cardiovascular safety profiles of aromatase inhibitors : A comparative review

Drug safety, 2006-01, Vol.29 (9), p.785-801

2006

Volltextzugriff (PDF)

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Volltextzugriff (PDF)

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Journal of pain and symptom management, 2000-03, Vol.19 (3), p.193-199

2000

Volltextzugriff (PDF)

Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer

Clinical breast cancer, 2003-08, Vol.4 (3), p.187-192

2003

Volltextzugriff (PDF)

Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study

Radiotherapy and oncology, 2001-02, Vol.58 (2), p.131-136

2001

Volltextzugriff (PDF)

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (herceptin)

Seminars in oncology, 2001-02, Vol.28 (1D), p.1-12, Article asonc0280001d

2001

Volltextzugriff (PDF)

Main implications related to the switch to BRCA 1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Oncotarget, 2018-04, Vol.9 (28), p.19463-19468

2018

Volltextzugriff (PDF)

HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials

Clinical breast cancer, 2002-10, Vol.3, p.S75-S79

2002

Volltextzugriff (PDF)

Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.596-596

2022

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(60)

Sprache

Englisch
(59)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Female
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Breast Neoplasms - Drug Therapy
(22)
Oncology
(21)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Breast Neoplasms - Pathology
(12)
Aged
(9)
Middle Aged
(9)
Pharmacology. Drug Treatments
(9)
Adult
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Treatment Outcome
(8)
Taxoids
(7)
Anastrozole
(6)
Antineoplastic Agents
(6)
Antineoplastic Agents - Adverse Effects
(6)
Chemotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
Cancer
(9)
Seminars In Oncology
(8)
Cancer Research
(5)
Clinical Breast Cancer
(3)
Oncotarget
(2)
The Oncologist
(2)
The oncologist
(2)
Blood
(1)
Breast Cancer Research And Treatment
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

The emerging role of aromatase inhibitors in the adjuvant management of breast cancer

Monotherapy of Metastatic Breast Cancer: A Review of Newer Agents

Ocular toxicity and cancer chemotherapy: A review

Docetaxel in the treatment of breast cancer: An update on recent studies

Cardiovascular safety profiles of aromatase inhibitors : A comparative review

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer

Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (herceptin)

Main implications related to the switch to BRCA 1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials

Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant

Aktive Filter

Suchergebnisse filtern